News
LEXINGTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today plans ...
LEXINGTON, Mass., Oct. 13, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today plans ...
T2 Biosystems ($TTOO) inked an $8.5 million deal with Canon U.S. Life Sciences to develop a rapid diagnostic test for Lyme disease, expanding its offerings and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback